cystadrops 3.8 mgml
medison pharma ltd - mercaptamine as hydrochloride - ophthalmic solution - mercaptamine as hydrochloride 3.8 mg - mercaptamine - cystadrops is indicated for the treatment of corneal cystine crystal deposits in adults and children from 2 years of age with cystinosis.
cystaran 0.44% eye drops
imported (united states) - mercaptamine hydrochloride - eye drops - 4.4mg/1ml
cystagon
recordati rare diseases - mercaptamine bitartrate - cystinosis - other alimentary tract and metabolism products, - cystagon is indicated for the treatment of proven nephropathic cystinosis. cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.
procysbi
chiesi farmaceutici s.p.a - mercaptamine bitartrate - cystinosis - other alimentary tract and metabolism products, - procysbi is indicated for the treatment of proven nephropathic cystinosis. cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.
dropcys
lucane pharma - mercaptamine - corneal diseases; cystinosis - treatment of corneal cystine deposits,
cystadrops solution
recordati rare diseases canada inc - cysteamine (cysteamine hydrochloride) - solution - 0.37% - cysteamine (cysteamine hydrochloride) 0.37% - eent drugs, miscellaneous
procysbi 25mg gastro-resistant capsules
chiesi ltd - mercaptamine bitartrate - gastro-resistant capsule - 25mg
procysbi 75mg gastro-resistant capsules
chiesi ltd - mercaptamine bitartrate - gastro-resistant capsule - 75mg
cystagon 150mg capsules
orphan europe (uk - mercaptamine bitartrate - capsule - 150mg
cystagon 50mg capsules
orphan europe (uk - mercaptamine bitartrate - capsule - 50mg